Literature DB >> 29286922

lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma.

Chun Zhang1, Xi Yang2, Quan Qi3, Yuhai Gao4, Qiang Wei4, Shuwen Han3.   

Abstract

BACKGROUND: Chronic hepatitis C (CHC) is a contagious liver disease that results from infection with the hepatitis C virus (HCV). The most serious consequence of CHC is HCV-related hepatocellular carcinoma (HCC).
OBJECTIVE: To illustrate the clinical significance of lncRNA HEIH expression in serum and exosomes in the development of HCV-related HCC.
METHODS: Thirty-five CHC, twenty-two HCV-induced cirrhosis and ten HCV-related HCC patients in Huzhou Central Hospital from January 2016 to September 2016 were recruited in the present study. Basic patient information, clinical serological indicators, and clinical imaging data were investigated and analyzed. Serum samples were collected from patients after receiving informed consent. Exosomes were extracted from the serum, and electron microscopy was used to observe the ultrastructure of exosomes. Quantitative PCR was used to detect lncRNA HEIH gene expression in serum and exosomes.
RESULTS: The changes in the ALT, GGT, HDL, INR, Alb and AFP levels in the patients with HCV-induced cirrhosis and HCV-related HCC were statistically significant. In patients with HCV-related HCC, lncRNA-HEIH expression in serum and exosomes was increased, but the ratio of lncRNA-HEIH expression in serum versus exosomes was decreased compared to patients with CHC.

Entities:  

Keywords:  Chronic hepatitis C; HEIH; cirrhosis; exosome; hepatocellular carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29286922     DOI: 10.3233/CBM-170727

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  56 in total

Review 1.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

Review 2.  The functional roles of exosomes-derived long non-coding RNA in human cancer.

Authors:  Feiyu Chen; Ning Wang; Hor-Yue Tan; Wei Guo; Cheng Zhang; Yibin Feng
Journal:  Cancer Biol Ther       Date:  2019-02-11       Impact factor: 4.742

3.  LncRNA HEIH regulates cell proliferation and apoptosis through miR-4458/SOCS1 axis in triple-negative breast cancer.

Authors:  Peng Li; Bo Zhou; Yuetao Lv; Qian Qian
Journal:  Hum Cell       Date:  2019-08-27       Impact factor: 4.174

Review 4.  Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.

Authors:  Changbiao Li; Xiao Xu
Journal:  Cell Mol Life Sci       Date:  2019-07-12       Impact factor: 9.261

5.  Bone marrow mesenchymal stem cells-secreted exosomal H19 modulates lipopolysaccharides-stimulated microglial M1/M2 polarization and alleviates inflammation-mediated neurotoxicity.

Authors:  Lu Zong; Pu Huang; Qing Song; Yan Kang
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 6.  Long non-coding RNAs (LncRNAs), viral oncogenomics, and aberrant splicing events: therapeutics implications.

Authors:  Rodney Hull; Zukile Mbita; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

Review 7.  Clinical implications of exosome-derived noncoding RNAs in liver.

Authors:  Zhe Wen Zhou; Wei Zheng; Zheng Xiang; Cun Si Ye; Qiao Qiao Yin; Shou Hao Wang; Cheng An Xu; Wen Hao Wu; Tian Chen Hui; Qing Qing Wu; Ling Yun Zhao; Hong Ying Pan; Ke Yang Xu
Journal:  Lab Invest       Date:  2022-01-10       Impact factor: 5.662

8.  Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR-650/TIMP3 axis.

Authors:  Wei Liang; Jinyuan Ke
Journal:  Int J Exp Pathol       Date:  2022-02-13       Impact factor: 1.925

Review 9.  Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.

Authors:  Juan Wang; Xiaoya Wang; Xintong Zhang; Tingting Shao; Yanmei Luo; Wei Wang; Yunwei Han
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

Review 10.  Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment.

Authors:  Mengtao Xing; Xinzhi Wang; Robert A Kiken; Ling He; Jian-Ying Zhang
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.